| ZP2 |
Q05996
|
zona pellucida glycoprotein 2
|
|
6.2E-08 |
0.931 |
|
2
|
| ZP1 |
P60852
|
zona pellucida glycoprotein 1
|
|
1.9E-21 |
0.890 |
|
2
|
| RBSN |
Q9H1K0
|
rabenosyn, RAB effector
|
|
2.3E-02 |
1.000 |
|
1
|
| SLFN14 |
P0C7P3
|
schlafen family member 14
|
|
3.5E-09 |
0.931 |
|
1
|
| RGS9BP |
Q6ZS82
|
regulator of G protein signaling 9 binding protein
|
|
2.3E-03 |
0.931 |
|
1
|
| SPG41 |
|
spastic paraplegia 41 (autosomal dominant)
|
|
|
1.000 |
|
1
|
| CFAP43 |
Q8NDM7
|
cilia and flagella associated protein 43
|
|
1.3E-22 |
0.931 |
0.038 |
1
|
| DYT17 |
|
dystonia 17
|
|
|
1.000 |
0.038 |
1
|
| SEPTIN14 |
Q6ZU15
|
septin 14
|
|
6.9E-06 |
0.805 |
0.077 |
2
|
| RAB28 |
P51157
|
RAB28, member RAS oncogene family
|
|
2.5E-02 |
0.792 |
0.077 |
1
|
| GAPVD1 |
Q14C86
|
GTPase activating protein and VPS9 domains 1
|
Enzyme modulator
|
1.00 |
1.000 |
0.077 |
1
|
| CEP83 |
Q9Y592
|
centrosomal protein 83
|
|
4.3E-14 |
0.839 |
0.077 |
1
|
| RELT |
Q969Z4
|
RELT TNF receptor
|
|
1.1E-06 |
0.821 |
0.077 |
1
|
| SPG19 |
|
spastic paraplegia 19 (autosomal dominant)
|
|
|
0.931 |
0.077 |
1
|
| ODAPH |
Q17RF5
|
odontogenesis associated phosphoprotein
|
|
5.0E-02 |
0.839 |
0.077 |
1
|
| SPG24 |
|
spastic paraplegia 24 (autosomal recessive)
|
|
|
0.931 |
0.077 |
1
|
| SCA25 |
|
spinocerebellar ataxia 25
|
|
|
0.931 |
0.077 |
1
|
| SCA20 |
|
spinocerebellar ataxia 20
|
|
|
1.000 |
0.077 |
1
|
| SPG29 |
|
spastic paraplegia 29 (autosomal dominant)
|
|
|
0.931 |
0.077 |
1
|
| SPG34 |
|
spastic paraplegia 34 (autosomal dominant)
|
|
|
1.000 |
0.077 |
1
|
| NUTM2A |
Q5VT03 Q8IVF1
|
NUT family member 2A
|
|
5.4E-07 |
0.805 |
0.077 |
1
|
| SPG37 |
|
spastic paraplegia 37 (autosomal dominant)
|
|
|
1.000 |
0.077 |
1
|
| SCA30 |
|
spinocerebellar ataxia 30
|
|
|
0.931 |
0.077 |
1
|
| DYT21 |
|
dystonia 21, torsion (autosomal dominant)
|
|
|
0.931 |
0.077 |
1
|